8028 Safety analysis of trabectedin in combination with pegylated liposomal doxorubicin (PLD) vs PLD alone in ovarian cancer patients 65 years of age and older

Journal article

Peer reviewed

I. Vergote, J. Vermorken, E. Pujade-Lauraine, B. Monk, A. Lisyanskaya, J. Rolski, S. Vasanthan, P. Santabárbara, E. Bayever and A. Poveda

European journal of cancer supplements, Vol.7(2), pp.458-458

2009

Metrics

4 Record Views

Title: 8028 Safety analysis of trabectedin in combination with pegylated liposomal doxorubicin (PLD) vs PLD alone in ovarian cancer patients 65 years of age and older
Creators: I. Vergote
J. Vermorken
E. Pujade-Lauraine
B. Monk
A. Lisyanskaya
J. Rolski
S. Vasanthan
P. Santabárbara
E. Bayever
A. Poveda
Publication Details: European journal of cancer supplements, Vol.7(2), pp.458-458
Identifiers: 991005969048202656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article